Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
about
Neuropharmacological effect of methylphenidate on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopyNeuropharmacological effect of atomoxetine on attention network in children with attention deficit hyperactivity disorder during oddball paradigms as assessed using functional near-infrared spectroscopySystematic review of atomoxetine data in childhood and adolescent attention-deficit hyperactivity disorder 2009-2011: focus on clinical efficacy and safety.Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findingsAcute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: a fNIRS study.Individual classification of ADHD children by right prefrontal hemodynamic responses during a go/no-go task as assessed by fNIRS.A quick test of cognitive speed for comparing processing speed to differentiate adult psychiatric referrals with and without attention-deficit/hyperactivity disorders.Efficacy and safety of atomoxetine in the treatment of children and adolescents with attention deficit hyperactivity disorderThe efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.Validation of the AQT color-form additive model for screening and monitoring pharmacological treatment of ADHD.Right prefrontal activation as a neuro-functional biomarker for monitoring acute effects of methylphenidate in ADHD children: An fNIRS study.Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients' emotional expression during psychostimulant or nonstimulant ADHD treatment.
P2860
Q28647972-B0C8F543-E126-4F6F-8224-5044CF71D62FQ28647973-561FA15D-92A7-47FF-BE38-7D8655AFD0D9Q30593927-20F7BE25-D422-473C-A794-FFAE278E25A4Q33722315-82B960CE-4504-4AD9-9BAA-E515EAC1FA01Q34431858-F2D364AF-F693-4570-A6AC-61E2B2779A72Q35925567-A5A36D2D-674C-48A6-9EC9-DE04A2730AF6Q36182701-42CB746F-90AB-4B48-967D-0200FE5CF561Q36751226-D31D9283-6EB3-4BFE-A84D-B6987DAF3DFEQ38362252-8675DD2D-FE04-40EB-BD79-B7BFC88FA1C2Q38478377-010C2AA8-A446-4CF0-93A5-42B6323BEB0BQ42577413-51AEBBEC-30B2-44AE-802E-EBED919F5AAFQ43875145-7893FAED-D6DB-4B67-845C-8C214BDCA57D
P2860
Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Atomoxetine treatment and ADHD ...... , their parents and physicians
@en
Atomoxetine treatment and ADHD ...... their parents and physicians.
@nl
type
label
Atomoxetine treatment and ADHD ...... , their parents and physicians
@en
Atomoxetine treatment and ADHD ...... their parents and physicians.
@nl
prefLabel
Atomoxetine treatment and ADHD ...... , their parents and physicians
@en
Atomoxetine treatment and ADHD ...... their parents and physicians.
@nl
P2093
P2860
P356
P1476
Atomoxetine treatment and ADHD ...... , their parents and physicians
@en
P2093
Alexander Schacht
Anette Minarzyk
Gerd Lehmkuhl
Kathrin Sevecke
Martin Lehmann
Peter M Wehmeier
Ralf W Dittmann
P2860
P2888
P356
10.1186/1753-2000-3-21
P577
2009-08-24T00:00:00Z
P5875
P6179
1008655750